Search Results 1781-1790 of 17087 for monoclonal antibody

1. Thrombin, bovine (topical application route) - Side effects & uses - Mayo Clinic

   Bovine thrombin or factor V antibodies, known or suspected—Should not be used in patients with these conditions. Bleeding problems or; Blood clotting ...

2. Panobinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   quantitative IgM monoclonal protein > 1,000 mg/dL. ANC ≥ 1000/uL; Hgb ≥ 9 g/dl; PLT ≥ 75,000/uL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if ...

3. A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy - Mayo Clinic

   Documented allergic reactions or similar to antibody treatments; Concurrent malignancies other than BCC, other than those with negligible risk of metastases ...

4. Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma - Mayo Clinic

   Completion of, if applicable, radiotherapy, chemotherapy, antibodies and immunoconjugates including brentuximab vedotin and/or another investigational drug ...

5. Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis - Mayo Clinic

   Presence of anti-mitochondrial antibodies (AMA) in serum (≥ 1:40 on immunofluorescence); Liver histological (based on liver biopsy) findings consistent with ...

6. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

   Participants must have disease that is measurable by either serum or urine evaluation of the monoclonal component or by assay of serum free light chains or ...

7. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Positive for anti-centromere antibodies with the exception that subjects who are positive for both anti-centromere and anti-topoi. Note: Other protocol ...

8. Clinical trials - Oncology (Medical)

   UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...

9. Influenza virus vaccine recombinant (intramuscular route) - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. It is also known as a “flu shot". Influenza is a ...

10. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

    Positive screening for human immunodeficiency virus antibodies, hepatitis B surface antigen, or hepatitis C virus antibodies. 23. Known history of or active ...